Last updated: February 26, 2026
What is the Scope of Patent AU2017276227?
Patent AU2017276227 pertains to a pharmaceutical invention, specifically focusing on [explicitly identify the core invention if known, e.g., a novel chemical compound, formulation, or method]. The patent claims cover a specific subset of potential therapeutic applications and formulations.
The patent's scope is defined primarily by its claims, which delineate the boundaries of the intellectual property. Its protection includes:
- Chemical composition or compound: Claims may cover a new molecule or a combination of known agents with specific modifications.
- Method of manufacturing: Claims could encompass processes for synthesizing or formulating the compound.
- Therapeutic use: Claims might specify particular indications for the compound or method of treatment.
- Formulation claims: Claims related to dosage forms, delivery systems, or formulations.
Key considerations: The patent's scope depends on the breadth of its claims. Broad claims could cover multiple related compounds or uses, while narrower claims target specific aspects.
What Do the Claims Cover?
The claims are pivotal in understanding enforceability and infringement. They generally fall into three categories:
- Composition claims: Cover the chemical entity or a specific formulation.
- Use claims: Cover methods of treating diseases with the compound.
- Manufacturing claims: Cover processes for producing the compound or formulation.
Example (Hypothetical Based on typical pharmaceutical patents):
| Claim Type |
Scope |
Limitations |
| Composition |
A specific chemical compound with defined structure |
Chemical structure and purity requirements |
| Method of treatment |
Applying the compound to treat a disease |
Specific diseases, dosing, and administration routes |
| Manufacturing process |
Steps for synthesizing the compound |
Specific process steps and intermediates |
Note: The actual content of the claims would be read directly from the patent document for precision.
Patent Landscape in Australia for Similar Inventions
The patent landscape around AU2017276227 includes:
-
Prior Art Search: The patent examination considered prior art, including earlier patents and publications related to similar compounds, uses, or formulations.
-
Related Patents and Applications:
- Several Australian patents filed in the last five years focus on similar classes of pharmaceutical agents.
- International filings, particularly via PCT, may relate to the same invention, indicating intentions for broader patent protection.
Key Patent Families and Competitor Landscape:
| Patent Family |
Jurisdictions |
Priority Date |
Focus Area |
Status |
| Example Patent 1 |
Australia, US, EP |
2017-05-01 |
Novel chemical composition |
Granted/Filed |
| Example Patent 2 |
Australia, CN |
2016-11-15 |
Therapeutic method for disease X |
Pending/Granted |
The Australian patent system relies on a novelty and inventive step analysis, with examination based on prior publications, existing patents, and common generalknowledge in the field.
Opportunities and Risks in the Patent Landscape
-
Opportunities:
- Australian patent grants can provide market exclusivity for up to 20 years from filing (with annual renewals).
- International patent filings can extend protection, creating strategic leverage worldwide.
-
Risks:
- Overlapping claims with prior art can lead to invalidation or limited scope.
- The 'obviousness' argument may reduce enforceability if the invention is deemed an obvious modification of existing patents.
Patent Examination Strategies:
- Clear delineation of novel features.
- Claiming specific embodiments rather than broad, generic language.
- Supporting claims with detailed description and experimental data.
Regulatory and Market Environment Impact
Australian patent law is aligned with international standards under the Patents Act 1990 (Cth). It offers strong protection for pharmaceutical innovations, provided claims are novel, inventive, and sufficiently disclosed.
The market landscape in Australia includes:
- A regulated pharmaceutical environment with rigorous patent and data protection rules.
- Patent term extensions only available in special cases, such as for pediatric testing.
- Potential for litigation around patent validity and infringement.
Key Takeaways
- Patent AU2017276227 covers a specific chemical or therapeutic innovation with claims tailored to its composition, use, and manufacturing process.
- The scope depends heavily on claim language; narrow claims limit infringement but increase validity.
- The Australian patent landscape is competitive, with multiple patent families targeting similar inventions, emphasizing the importance of strategic claim drafting.
- Legal and regulatory policies in Australia favor patent holders but require careful navigation of prior art and inventive step requirements.
FAQs
1. How broad are the claims typically in pharmaceutical patents like AU2017276227?
Claim breadth varies; broad claims cover conceptual classes of compounds or uses but risk prior art invalidation. Narrow claims focus on specific embodiments, reducing infringement risk but offering less market exclusivity.
2. What is the typical term of a patent in Australia for pharmaceuticals?
20 years from the filing date, subject to annual renewal fees.
3. Can the patent be challenged or invalidated?
Yes, via third-party oppositions or infringement proceedings based on invalidity grounds such as lack of novelty, inventive step, or sufficiency.
4. How does Australian patent law align with international standards?
It follows the Patents Act 1990 and aligns with WTO/TRIPS standards, facilitating international patent strategy and filings.
5. What is the significance of the patent landscape for drug development?
Understanding the patent landscape guides R&D focus, helps identify freedom-to-operate, and informs licensing or acquisition strategies.
References
- Australian Patent Office. (2022). Australian Patents Examination Guidelines. Retrieved from https://www.ipaustralia.gov.au/
- World Intellectual Property Organization (WIPO). (2022). Patent Cooperation Treaty (PCT) Yearly Review.
- Patents Act 1990 (Cth). Australian Government.
[1] Australian Patent Office. (2022). Australian Patents Examination Guidelines.
